Cosuda began sales in 2010 with the Peak Plasma Blade, Doxpal retractor and more recently the Beeline infusion pump. The Peak Plasma Blade highlighted the excellent relationships that Cosuda has established over the years with surgical professionals. The product was a highly technical product and expensive in the hospital system. With excellent results and rapport, Cosuda was able to establish this product in the Australian marketplace before the company (Peak Surgical) was acquired by Medtronic in 2011. Turnover was 2000 units for the 2 years Cosuda represented this product, we exceeded our sales goals by over 130% in each year. Since 2011, with successful rebate of the Beeline infusion pump, Cosuda has been able to quickly grow this pain management product to establish itself in the market as the now no.2 pain management product for disposable infusion device. With a current growth of 250% p.a, Cosuda has continued to grow positively since 2010 and recorded 3 successive profitable financial years whilst maintaining a tight control on fiscal policies. As a national distribution company, Cosuda will continue to see high growth rates through innovative products, increased sales, while pursuing better patient outcomes.